Patient groups call out silver linings that could emerge from COVID-19 crisis

While chronic disease patients are navigating unprecedented challenges in access to drugs and care during the COVID-19 crisis, the silver lining is that it is forcing the hands of legislators, regulators and payers to increase access to telemedicine and at-home infusions, which could benefit patients well beyond the pandemic.

Patients with chronic diseases typically need to travel to specialists for treatment and are at a greater risk of complications if they contract COVID-19. What's often overlooked is the toll those added risks, when combined with the disruptions in care imposed by the crisis, take on patients. The result is that patients must weigh the benefits of visiting a doctor or treatment center to receive necessary therapies with the risk of infection...